FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

6 results

bosulif
(Bosutinib)
Pfizer Laboratories Div Pfizer Inc
Usage: BOSULIF is indicated for treating chronic phase Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML) in adults and patients aged 1 and older, whether newly diagnosed or resistant/intolerant to prior therapies. It is also used for adult patients with accelerated or blast phases of Ph+ CML who are resistant/intolerant to prior treatments.
imatinib mesylate
(IMATINIB MESYLATE)
Camber Pharmaceuticals, Inc.
Usage: This drug is indicated for the treatment of newly diagnosed Philadelphia positive chronic myeloid leukemia (Ph+ CML), blast crisis, and acute lymphoblastic leukemia (ALL) in adults and pediatrics, as well as for myelodysplastic/myeloproliferative diseases, aggressive systemic mastocytosis, hypereosinophilic syndrome, dermatofibrosarcoma protuberans, and gastrointestinal stromal tumors.
imatinib mesylate
(Imatinib Mesylate)
Chartwell RX, LLC
Usage: This drug is indicated for treatment of Philadelphia positive chronic myeloid leukemia (CML) in various phases, acute lymphoblastic leukemia (ALL), myelodysplastic/myeloproliferative diseases, aggressive systemic mastocytosis, hypereosinophilic syndrome, chronic eosinophilic leukemia, dermatofibrosarcoma protuberans, and Kit+ gastrointestinal stromal tumors (GIST).
imatinib mesylate
(Imatinib Mesylate)
Apotex Corp
Usage: This drug is indicated for the treatment of newly diagnosed and resistant Philadelphia chromosome positive chronic myeloid leukemia (CML), acute lymphoblastic leukemia (ALL), various myelodysplastic/myeloproliferative diseases, aggressive systemic mastocytosis, hypereosinophilic syndrome, dermatofibrosarcoma protuberans, and gastro-intestinal stromal tumors (GIST).
sprycel
(dasatinib)
E.R. Squibb & Sons, L.L.C.
Usage: SPRYCEL (dasatinib) is indicated for treating adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (CML), resistant or intolerant Ph+ CML, and Ph+ acute lymphoblastic leukemia (ALL). It also treats pediatric patients aged 1 and older with Ph+ CML and newly diagnosed Ph+ ALL with chemotherapy.
tasigna
(nilotinib)
Novartis Pharmaceuticals Corporation
Usage: Tasigna is indicated for treating newly diagnosed Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in adults and pediatric patients (≥1 year). It is also used for adults and pediatric patients with resistant or intolerant Ph+ CML in chronic or accelerated phases after prior tyrosine-kinase inhibitor therapy.

Medications for Philadelphia Chromosome Positive Chronic Myelogenous Leukemia

bosulif

imatinib mesylate

imatinib mesylate

imatinib mesylate

sprycel

tasigna